Immersive Virtual Reality Exergames and Office Workers' Cardiometabolic Health

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorGuangzhou University

About this trial

The worldwide increasing of prevalence of non-communicable diseases has grown the recognition of necessity for identifying the modifiable risk in preventing and managing these diseases. While, the office worker, as a representative group of physical inactivity, is exposed to risk factor of metabolic syndrome which is considered as the pathway of non-communicable diseases. This study mainly focuses on the purpose of examining the interventional efficacy of at-home immersive virtual reality exergame on several metabolic syndrome biomarkers among office workers. In addition, it purposes to determine the impacts of at-home immersive virtual reality exergame on lifestyle pattern of office workers. A 2-armed, single blinded randomized controlled trial (RCT) will be applied to examine the therapeutic effects of at-home immersive virtual reality exergame in this exploratory study. 120 Japanese office workers with less than 150 minutes per week of moderate to vigorous sports activities will be recruited by a convenience sample method. They are randomly allocated to two parallel groups, which including an intervention group: 12-week training of at least 150 minutes per week at-home immersive virtual reality exergame playing with a set device of Meta Quest 2, a control group: 12-week of maintaining regular exercise, eating, and working habits without making significant changes. During this 12-week trial, 3 main follow up steps are included at the timelines of 0 week, 6 weeks, 12 weeks. For each follow up, we will collect three types of variables, including major clinical risk factors of metabolic syndrome, lifestyle pattern factors of metabolic syndrome, and demographics (0 week only). To analysis the variance between intervention group and control group, mixed linear model will be applied to understand the efficacy result of this intervention. The variances of metabolic syndrome clinical risk factors between groups would be used to express the therapeutic effects of at-home immersive virtual reality exergame. The changes of lifestyle pattern factors would be applied to show the impacts of at-home immersive virtual reality exergame on lifestyle pattern.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18-64 years old

Capable of standing and exercising.

Having no history of diagnosis of heart disease, cancer, or dementia.

Being interested in playing with the exergames.

Disqualifiers

Individuals who are already engaged in more than 150 minutes per week of moderate to vigorous activities.

Individuals with some pharmacological treatments, some surgery (bariatric surgery), and some traditional Chinese medicine.

Trial design

Design model

Parallel

Treatments tested in this trial

  • 12-week at-home immersive virtual reality exergame

    Behavioral

    12-week training of at least 150 minutes per week at-home immersive virtual reality exergame playing with a set device of Meta Quest 2 and maintaining regular eating and working habits without making significant changes.

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: 12-week at-home immersive virtual reality exergameExperimental treatment 1 intervention
Group B: 12-week control in awaitingNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

High-density lipoprotein cholesterol (HDL-C)

HDL-C concentration less than 35 mg/dl for men (39 mg/dl for women).

Time frame
Baseline (0 week), Mid-follow up (6-week), Final follow up (12-week).
2

Low-density lipoprotein cholesterol (LDL-C)

LDL-C \< 160 mg/dl

Time frame
Baseline (0 week), Mid-follow up (6-week), Final follow up (12-week).
3

Impaired fasting glucose

a fasting plasma glucose (FPG) concentration between 6.1 and 6.9 mmol/l.

Time frame
Baseline (0 week), Mid-follow up (6-week), Final follow up (12-week).
4

Triglycerides

Triglycerides concentration \> 150 mg/dl.

Time frame
Baseline (0 week), Mid-follow up (6-week), Final follow up (12-week).

Secondary outcomes

1

Exercise time (including exergaming time)

Total minutes of exercise time and exergaming time per week.

Time frame
Baseline (0 week, self estimation), Mid-follow up (1-6 week), Final follow up (7-12 week).
2

Sedentary time

Total minutes of sedentary time per week.

Time frame
Baseline (0 week, self estimation), Mid-follow up (1-6 week), Final follow up (7-12 week).

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: